BioSpace News Archive

Feb. 20, 2020 16:45 UTC The Phase 1/2a trial evaluates a novel route of administration for TG6002, an oncolytic virus that allows the production of chemotherapy agent directly in the tumor STRASBOURG, France--( BUSINESS WIRE )-- Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that the first patient has successfully received TG6002, vi

Feb. 20, 2020 17:15 UTC MADRID--( BUSINESS WIRE )-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced positive data presented today on its automated insulin delivery technologies, including data from a study of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology demonstrating increased time in range (70 mg/dL -180 mg/dL) 1 in children ages six to thirteen. In a separate presentation, r

Company Announced Positive Results from Its Phase 2 Type 1 Diabetes Trial Showing that TTP399 Lowered HbA1C, Decreased the Use of Insulin for Patients and Increased Time in Range